• Je něco špatně v tomto záznamu ?

Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid

MM. Kaiser, L. Poštová-Slavětínská, M. Dračínský, YJ. Lee, Y. Tian, Z. Janeba,

. 2016 ; 108 (-) : 374-80. [pub] 20151212

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000730

The lack of antiviral activity of recently described (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid, or (S)-CPMEA in brief, has been speculated to possibly be due to the increased hydrophilicity of the molecule and, thus, by its limited cellular permeability. Efficient syntheses of novel lipophilic prodrugs of (S)-CPMEA masking either the carboxylic group or preferably both the phosphonate and carboxylic moieties, have been developed in order to increase bioavailability of the parent compound. Two prodrugs of (S)-CPMEA, namely phosphonate bis-amidate 15 and phenyloxy amidate 16, exhibited pan-genotypic anti-HCV activity at submicromolar concentrations.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000730
003      
CZ-PrNML
005      
20170116095254.0
007      
ta
008      
170103s2016 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ejmech.2015.12.009 $2 doi
024    7_
$a 10.1016/j.ejmech.2015.12.009 $2 doi
035    __
$a (PubMed)26706348
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Kaiser, Martin Maxmilian $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, CZ-16610, Prague 6, Czech Republic.
245    10
$a Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid / $c MM. Kaiser, L. Poštová-Slavětínská, M. Dračínský, YJ. Lee, Y. Tian, Z. Janeba,
520    9_
$a The lack of antiviral activity of recently described (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid, or (S)-CPMEA in brief, has been speculated to possibly be due to the increased hydrophilicity of the molecule and, thus, by its limited cellular permeability. Efficient syntheses of novel lipophilic prodrugs of (S)-CPMEA masking either the carboxylic group or preferably both the phosphonate and carboxylic moieties, have been developed in order to increase bioavailability of the parent compound. Two prodrugs of (S)-CPMEA, namely phosphonate bis-amidate 15 and phenyloxy amidate 16, exhibited pan-genotypic anti-HCV activity at submicromolar concentrations.
650    _2
$a adenin $x analogy a deriváty $x chemická syntéza $x chemie $x farmakologie $7 D000225
650    _2
$a antivirové látky $x chemická syntéza $x chemie $x farmakologie $7 D000998
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a Hepacivirus $x účinky léků $7 D016174
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a molekulární struktura $7 D015394
650    _2
$a organofosfonáty $x chemická syntéza $x chemie $x farmakologie $7 D063065
650    _2
$a prekurzory léčiv $x chemická syntéza $x chemie $x farmakologie $7 D011355
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Poštová-Slavětínská, Lenka $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, CZ-16610, Prague 6, Czech Republic.
700    1_
$a Dračínský, Martin $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, CZ-16610, Prague 6, Czech Republic.
700    1_
$a Lee, Yu-Jen $u Gilead Sciences, Inc., Foster City, CA, 94404, USA.
700    1_
$a Tian, Yang $u Gilead Sciences, Inc., Foster City, CA, 94404, USA.
700    1_
$a Janeba, Zlatko $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v.v.i., Flemingovo nám. 2, CZ-16610, Prague 6, Czech Republic. Electronic address: janeba@uochb.cas.cz.
773    0_
$w MED00001628 $t European journal of medicinal chemistry $x 1768-3254 $g Roč. 108, č. - (2016), s. 374-80
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26706348 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170116095359 $b ABA008
999    __
$a ok $b bmc $g 1179870 $s 961297
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 108 $c - $d 374-80 $e 20151212 $i 1768-3254 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace